Evaluation of graft-host response for various tissue sources and animal models

Annals of the New York Academy of Sciences

Volumn 875, Issue , 1999, Pages 233-254

  Weber, Collin J ^a   Safley, Susan ^a   Hagler, Mary ^a   Kapp, Judith ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANTIBODY; CYTOKINE; HYBRID PROTEIN; IMMUNOGLOBULIN; INSULIN; POLYLYSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; BIOCOMPATIBILITY; BIOPSY; CELL DESTRUCTION; CELL INTERACTION; CELL SURVIVAL; CELL TRANSPLANTATION; CONFERENCE PAPER; DOG; GENETIC MANIPULATION; GRAFT REJECTION; GRAFT SURVIVAL; HELPER CELL; IMMUNE RESPONSE; IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MACROPHAGE; MEMBRANE TRANSPORT; MICROCAPSULE; MOUSE; NONHUMAN; NUTRIENT; PANCREAS ISLET CELL; PERITONEAL CAVITY; PRIMATE; RABBIT; RAT; RODENT; SWINE; T LYMPHOCYTE; XENOGRAFT;

ANIMALIA; CANIS FAMILIARIS; ORYCTOLAGUS CUNICULUS; PRIMATES; RODENTIA; SUS SCROFA;

EID: 0032774732     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08507.x     Document Type: Conference Paper

References (89)

1. 1. THE DIABETES CONTROL AND COMPLICATIONS TRIALS RESEARCH GROUP. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl. J. Med. 329: 977-986.
2. 2. LACY, P. 1993. Status of islet cell transplantation. Diabetes Rev. 1: 76-92.
3. 3. BARKER, C. & A. NAJI. 1992. Perspectives on islet transplantation for diabetes - cures or curiosities? New Engl. J. Med. 327: 1861-1868.
4. 4. WARNOCK, G. & R. RAJOTTE. 1992. Human pancreatic islet transplantation. Transplant. Rev. 6: 195-208.
5. 5. LIPES, M., R. COOPER, R. SKELLY, C. RHODES, E. BOSCHETTI, G. WEIR & A. DAVALLI. 1996. Insulin-secreting non-islet cells are resistant to autoimmune destruction. Proc. Natl. Acad. Sci. USA 93: 8595-8600.
6. 6. GROS, L., MONTOLIU, E. RIU, F. LEBRIGAND & F. BOSCH. 1997. Regulated production of mature insulin by non-β-cells. Human Gene Ther. 8: 2249-2259.
7. 7. MITANCHEZ, D., B. DOIRON, R. CHEN & A. KAHA. 1997. Glucose-stimulated genes and prospects of gene therapy for type I diabetes. Endocrine Rev. 18: 520-540.
8. 8. DOCHERTY, K. 1997. Gene therapy for diabetes mellitus. Clin. Sci. 92: 321-330.
9. 9. RICORDI, C., E. FINKE & P.A. LACY. 1986. Method for the mass isolation of islets from the adult pig pancreas. Diabetes 35: 649-653.
10. 10. GIANNARELLI, R., P. MARCHETTI, G. VILLANI, A. DE CARLO, S. COSIMI, M. ANDREOZZI, L. CRUSHELLI, P. MASIECO, A. COPPELLI & P. NAVALESI. 1994. Preparation of pure, viable porcine and bovine islets by a simple method. Transplant. Proc. 26: 630-631.
11. 11. Jos, V., J. CONNOLLY, D. DEARDON, R. PEARSON, N. PARROTT & R. JOHNSON. 1994. A simple method for islet isolation from the rabbit pancreas. Transplantation 58: 390-392.
12. 12. LENSCHOW, D., Y. ZENG, J. THISTLETHWAITE, A. MONTAG, W. BRADY, M. GIBON, P. LINSLEY & J. BLUESTONE. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA41g. Science 257: 789-795.
13. 13. WEBER, C., R. HARDY, S. RIVER, D. BAILEY-BRAXTON, R. MICHLER, W. THOMAS, J. CHABOT, F. PI-SUNYER, M. WOOD & K. REEMTSMA. 1986. Diabetic mouse bioassay for functional and immunologic human and primate islet xenograft survival. Transplant. Proc. 18: 823-828.
14. 14. AKITA, L., M. OGAWA & T. MANDEL. 1994. Effect of FK506 and anti-CD4 therapy on fetal pig pancreas xenografts and host lymphoid cells in NOD/Lt, CBA, and BALB/c mice. Cell Transplant. 3: 61-73.
15. 15. RICORDI, C., P. LACY, K. STERBENZ & M. DAVIE. 1987. Low-temperature culture of human islets plus in vivo treatment of L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival. Proc. Natl. Acad. Sci. USA 84: 8080-8084.
16. 16. WEBER, C., M. COSTANZO, S. ZABINSKI, S. KREKUN, T. KOSCHITZKY, V. D'AGATI, L., WICKER, R. RAJOTTE & K. REEMTSMA. 1992. Zenografts of microencapsulated rat, canine, porcine, and human islets into streptozotocin (SZN) - and spontaneously diabetic NOD mice. In Pancreatic Islet Transplantation. C. Ricordi, Ed.: 177-190 R.G. Landes. Austin, TX.
17. 17. WEBER, C. & K. REEMTSMA. 1994. Microencapsulation in small animals-II: Xenografts. In Pancreatic Islet Transplantation Series: Vol. III: Immunoisolation of Pancreatic Islets. R. Lanza & W. Chick, Eds.: 59-79. R. Landes. Austin, TX.
18. 18. KORBUTT, G., J. ELLIOTT, Z. AO, D. SMITH, G. WARNOCK & R. RAJOTTE. 1996. Large scale isolation, growth, and function of porcine neonatal islet cells. J. Clin. Invest. 97: 2119-2129.
19. 19. SUN, Y., X. MA, D. ZHOU, I. VACEK & A. SUN. 1996. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immnosuppression. J. Clin. Invest. 98: 1417-1422.
20. 20. AUCHINCLOSS, H., JR. & D. SACHS. 1998. Xenogeneic transplantation. Annu. Rev. Immunol. 16: 433-470.
21. 21. PATIENCE, C., T. TAKEUCHI & R. WEIS. 1997. Infection of human cells by an endogenous retrovirus of pigs. Nature-Med. 13: 282-286.
22. 22. FISHMAN, J. 1994. Miniature swine as organ donors for man: strategies for prevention of xenotransplant-associated infections. Xenotransplantation 1: 47-57.
23. 23. HENEINA, W., A. TIBELL, W. STITZER, P. SANDSTROM, G. VAZQUEZ ROSALES, A. MATTHEWS, O. KORSGREN, T. CHAPMAN, C. FOLKS & C. GROTH. 1998. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Nature 352: 695-699.
24. 24. FAUSTMAN, D. & C. COE. 1991. Prevention of xenograft rejection by marking donor HLA class I antigens. Science 252: 1700-1702.
25. 25. COLTON, C. & E. AVGOUSTINIATOS. 1991. Bioengineering in development of the hybrid artificial pancreas. J. Biochem. Eng. 113: 152-170.
26. 26. SCHARP, D., C. SWANSON, B. OLACK, P. LATTA, O. HEGRE, E. DOHERTY, F. GENTILE, K. FLAVIN, M. ANSARA & P. LACY. 1994. Protection of encapsulated human islets implanted without immunosuppression in patients with Type I or Type II diabetes and in nondiabetic control subjects. Diabetes 43: 1167-1170.
27. 27. RICKER, A., S. STOCKBERGER, P. HALBAN, G. EISENBARTH & S. BONNER-WEIR. 1986. Hyperimmune response to microencapsulated xenogeneic tissue in non obese diabetic mice. In The Immunology of Diabetes Mellitus. M. Jaworski, Ed.: 193-200. Elsevier. Amsterdam.
28. 28. WEBER, C., S. ZABINSKI, J. NORTON, T. KOSCHITZKY, V. D'AGATI & K. REEMTSMA. 1989. The future role of microencapsulation in xenotransplantation. In Xenograft 25. M. Hardy, Ed.: 297-308. Elsevier. Amsterdam.
29. + helper T cells in destruction of microencapsulated islet xenografts in NOD mice. Transplantation 49: 396-404.
30. 30. SIEBERS, U., T. ZEKORN, A. HORCHER, G. KLOCK, R. HOUBEN, H. FRANK, R.G. BRETZEL, U. ZIMMERMANN & K. FEDERLIN. 1994. Microencapsulated transplantation of allogeneic islets into specifically presensitized recipients. Transplant. Proc. 26: 787-788.
31. 31. LANZA, R., W. KUHTREIBER, D. ECKER, J. STARUK & W. CHICK. 1995. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation 59: 1377-1384.
32. 32. SOON-SHIONG, P., E. FELDMAN, R. NELSON, J. KOMTEBEDDE, O. SMIDSROD, G. SKUAKBRAEK, T. ESPEVIK, R. HEINTZ & M. LEE. 1992. Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 54: 769-774.
33. 33. SOON-SHIONG, P., R.E. HEINTZ, N. MERIDETH, Q.X. YAO, Z. YAO, T. ZHENG, M. MURPHY, M.K. MOLONEY, M. SCHMEHL, M. HARRIS, R. MENDEZ & P.A. SANDFORD. 1994. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343: 950-951.
34. 34. HALLE, J., S. BOURASSA, F. LEBLOND, S. CHEVALIER, M. BEAUDRY, A. CHAPDELAINE, S. COUSINEAU, J. SAINTONGE & J. YALE. 1993. Protection of islets of Langerhans from antibodies by microencapsulation with alginate-poly-1-lysine membranes. Transplantation 44: 350-354.
35. 35. JARPE, A., M. HICKMAN & J. ANDERSON. 1990. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of model of autoimmune insulitis for Type 1 diabetes. Regional Immunol. 3: 305-317.
36. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 140: 52-58.
37. 37. HASKINS, K., M. PORTAS & B. BRADLEY. 1988. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37: 1444-1448.
38. 38. JANSEN, A., F. HOMO-DELARCHE, H. HOOIJKAAS, P. LEENEN, M. DARDENNE & H. DREXHAGE. 1994. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and B-cell destruction in NOD mice. Diabetes 43: 667-674.
39. 39. GELBER, C., L. PABROSKY, S. SINGER, D. MCATEER, R. TISCH, C. JOLICOEUR, R. BUELOW, H. MCDEVITT & G. FATHMAN. 1994. Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes. Diabetes 43: 33-39.
40. 40. PODOLIN, R., A. PRESSEY, N. DELARAATO, P. FISCHER, L. PETERSON & L. WICKER. 1993. I-E+ nonobese diabetic mice develop insulitis and diabetes. J. Exp. Med. 178: 803.
41. 41. KAUFMAN, D., M. CLARE-SALZLER & J. TIAN. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 365: 69-72.
42. 42. TISCH, R., X. YANG, S. SINGER, R. LIBLAU, L. FUGGER & H. MCDEVITT. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72-75.
43. 43. DYLAN, D., R. GILL, N. SCHLOOT & D. WEGMANN. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25: 1062.
44. 44. WANG, Y., L. HAO, R. GILL & K. LAFFERTY. 1987. Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes 36: 535-538.
45. 45. BOITARD, D., A. BENDELAC, M. RICHARD, C. CARNAUD & J. BACH. 1988. Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells. Proc. Natl. Acad. Sci. USA 85: 9719-9723.
46. 46. LAFFERTY, K. 1988. Circumventing rejection of islet grafts: an overview. In Transplantation of the Endocrine Pancreas in Diabetes Mellitus. R. Van Shilfgaarde & M. Hardy, Eds.: 279-291. Elsevier. Amsterdam.
47. 47. WEBER, C., J. PRICE, M. COSTANZO, A. BECKER & A. STALL. 1994. NOD mouse peritoneal cellular response to poly-1-lysine-alginate microencapsulated rat islets. Transplant. Proc. 26: 1116-1119.
48. 48. WEBER, C., A. TANNA, M. COSTANZO, J. PRICE, L. PETERSON & L. WICKER. 1994. Effects of host genetic background on survival or rat→mouse islet xenografts. Transplant. Proc. 26: 1186-1188.
49. 49. WUSMAN, J., P. ATKINSON & R. MAZHERI. 1992. Histological and immunopathological analysis of recovered encapsulated allogeneic islets from transplanted diabetic BB/W rats. Transplantation 54: 588-592.
50. 50. COLE, D., M. WATERFALL, M. MCINTYRE & J. BAIRD. 1992. Microencapsulated islet grafts in the B/E rat: a possible role for cytokines in graft failure. Diabetologia 35: 231-237.
51. 51. MAZAHERI, R., P. ATKINSON, C. STILLER, J. DUPRE, J. VOSE & G. O'SHEA. 1991. Transplantation of encapsulated allogeneic islets into diabetic BB/W rats: effects of immunosuppression. Transplantation 51: 750-754.
52. 52. DARQUY, S. & G. REACH. 1985. Immunoisolation of pancreatic B cells by microencapsulation. Diabetologia 28: 776-780.
53. 53. BALDWIN, W., S. PRUITT, R. BRAUER, M. DAHA & F. SANFILIPPO. 1995. Complement in organ transplantation. Transplantation 59: 797-808.
54. 54. IWATA, H., T. TAKAGI & H. AMEMIYA. 1992. Marked prolongation of islet xenograft survival (hamster-to-mouse) by microencapsulation and administration of 15-deoxyspergualin. Transplant. Proc. 24: 1517-1518.
55. 55. PIERSON, R., H. WINN, P. RUSSELL & H. AUCHINCLOSS. 1989. CD-4 positive lymphocytes play a dominant role in murine xenogeneic responses. Transplant. Proc. 21: 519-521.
56. + T cells are both necessary and sufficient for islet xenograft rejection. Transplant. Proc. 26: 1203-1204.
57. 57. RABINOVITCH, A., W. SUMOSKI, R. RAJOTTE & G. WARNICK. 1990. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J. Clin. Endocrinol. Metab. 71: 152-156.
58. 58. BERMANN, L., K. KRONCKE, D. SUSCHE, H. KOLB & V. KOLB-BACHOFEN. 1990. Cytokines on human pancreatic islet cells in monolayer culture. J. Clin. Endocrinol. Metab. 71: 152-156.
59. 59. ANDERSEN, H., K. JORGENSEN, J. EGEBERG, T. MANDRUP-POULSEN & J. NERUP. 1994. Nicotinamide preents Interleukin-I effects on cumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes 43: 770-777.
60. 60. CIRULLI, V., P. HALBAN & D. ROUILLEKR. 1993. Tumor necrosis factor-a modifies adhesion properties of rat islet B cells. J. Clin. Invest. 92: 1868-1876.
61. 61. CAMPBELL, I., A. ISCARO & L. HARRISON. 1988. Interferon gamma and tumor necrosis factor alpha: cytotoxicity to murine islets of Langerhans. J. Immunol. 141: 1325-1329.
62. 62. RABINOVITCH, A. 1994. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes 43: 613-621.
63. 63. ABLAMUNITS, V., F. BARANOVA, T. MANDRUP-POULSEN & J. NERUP. 1994. In vitro inhibition of I insulin release by blood mononuclear cells from insulin-dependent diabetic and healthy subjects: synergistic action of IL-1 and TNF. Cell Transplant. 3: 55-60.
64. 64. MANDRUP-POULSEN, T., K. BENDTZEN, C. DINARELLO & J. NERUP. 1987. Human tumor necrosis factor potentiates interleukin-1 mediated rate of pancreatic B-cell cytotoxicity. J. Immunol. 39: 4077-4082.
65. 65. MORRIS C., M. FUNG, S. SIMEONOVIC, D. WILSON & A. HAPEL. 1994. Cytokine expression in CDA/H mice following xenotransplantation of fetal pig proislets. Transplant. Proc. 26: 1304-1305.
66. 66. O'CONNELL, P., A. PACHEOCO-SILVA, P. NICKERSON, R. MUGGIA, M. BASTOS, V. KELLEY & STROM. 1993. Unmodified pancreatic islet allograft rejection results in preferential expression of certain T cell activation transcripts. J. Immunol. 150: 1093-1104.
67. 67. AGUILAR-DIOSDADA, M., D. PARKINSON, J. CORBETT, G. KWON, C. MARSHALL, R. GINGERICH, J. SANTIAGO & M. McDANIEL. 1994. Potential autoantigens in IDDM: expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the B-cell surface. Diabetes 43: 418-425.
68. 68. JENKINS, M. 1994. The ups and downs of T cell costimulation. Immunity 1: 443-446.
69. 69. HARDING, F., J. MCARTHUR, J. GROSS, D. RAULET & J. ALLISON. 1992. CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356: 607-609.
70. 70. HATHCOCK, K., G. LASZIO, H. DICKLER, J. BRADSHAW, P. LINSLEY & R. HODES. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262: 905-907.
71. 71. GUERDER, S., J. MEYERHOFF & R. FLAVELL. 1994. The role of the T cell costimulatory B7-1 in autoimmunity and the induction and maintenance of tolerance of peripheral antigen. Immunity 1: 155-166.
72. 72. BOLLING, S., L. TURKA, R. WEI, P. LINSLEY, C. THOMPSON & H. LIN. 1994. Inhibition of B7-induced CD28 T-cell activation with CTLA4Ig prevents cardiac allograft rejection: evidence for costimulation. Transplantation 57: 413-415.
73. 73. PEARSON, T., D. ALEXANDER, K. WINN, P. LINSLEY, R. LOWRY & C. LARSEN. 1994. Transplantation of tolerance induced by CTLA4-Ig. Transplantation 57: 1701-1706.
74. 74. LENSCHOW, D., S. Ho, H. SATTAR, L. RHEE, G. GRAY, N. NABAVI, K. HEROLD & J. BLUESTONE. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181: 1145-1155.
75. 75. DURIE, F., R. FAVA, T. FOY, A. ARUFFO, J. LEDBETTER & R. NOELLE. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261: 1328-1330.
76. 76. GIN, H., C. CADIC, C. BAQUEY & B. DUPUY. 1992. Peritoneal exudates from microencapsulated rat islets of Langerhans xenografted mice presenting characteristics of potentially cytotoxic non-specific inflammation. J. Microencapsulation 9: 489-494.
77. 77. CLAYTON, H., N. LONDON, P. COLLOBY, P. BELL & R. JAMES. 1991. The effect of capsule composition on the biocompatibility of alginate-poly-1-lysine capsules. J. Microencapsulation 8: 221-233.
78. 78. SOON-SHIONG, P., M. OTERLIE, G. SKJAK-BRAEK, O. SMIDSROD, R. HEINTZ, R.P. LANZA & T. ESPEVIK. 1991. An immunologic basis for the fibrotic reaction to implanted microcapsules. Transplant. Proc. 23: 758-759.
79. 79. DE VOS, P., G. WOLTERS & R. VANSCHILFGAARDE. 1994. Possible relationship between fibrotic overgrowth of alginate-polylysine-alginate microencapsulated pancreatic islets and the microcapsule integrity. Transplant. Proc. 26: 782-783.
80. 80. CHANG, T. 1992. Artificial cells in immobilization biotechnology. Artif. Cells & Immob. Biotechnol. 20: 1121-1143.
81. 81. LUM, Z., I. TAI, M. KRESTOW, J. NORTON, I. VACEK & A. SUN. 1991. Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes 40: 1511-1516.
82. 82. CHICHEPORTICHE, D. & G. REACH. 1988. In vitro kinetics of insulin release by microencapsulated rat islets: effect of the size of the microcapsules. Diabetologia 31: 54-57.
83. 83. HORCHER, A., T. ZEKORN, U. SIEBERS, G. KLOCK, H. FRANK, R. HOUBEN, R.G. BRETZEL., U. ZIMMEERMAN & K. FEDERLIN. 1994. Transplantation of microencapsulated islets in rate: evidence for induction of fibrotic overgrowth by islet alloantigens released from microcapsules. Transplant. Proc. 26: 784-786.
84. 84. WEBER, C., M. COSTANZO, S. KREKUN & V. D'AGATI. 1993. Causes of destruction of microencapsulated islet grafts: characteristics of a 'double-wall' poly-1-lysine-alginate microcapsule. Diabetes Nutr. Metab. 1: 167-171.
85. 85. WEBER, C.J., J.A. KAPP, M.K. HAGLER, S. SAFLEY, J.T. CHRYSSOCHOOS & E.L. CHAIKOF. 1999. In Encapsulation and Immobilization Techniques. R.Lanza, W. Chick & W. Kutreiber, Eds. Springer-Verlag. New York. In press.
86. 86. WEBER, C., V. D'AGATI, L. WARD, M. COSTANZO, R. RAJOTTE & K. REEMTSMA. 1993. Humoral reaction to microencapsulated rat, canine, porcine islet xenografts in spontaneously diabetic NOD mice. Transplant. Proc. 25: 462-463.
87. 87. WEBER, C., M. HAGLER, B. KONIECZNY, J. CHRYSSOCHOOS, R. RAJOTTE, F. LAKKIS & R. LOWRY. 1995. Encapsulated islet iso-, allo-, and xeno-grafts in diabetic NOD mice. Transplant. Proc. 27: 3308-3311.
88. 88. WEBER, C., M. HAGLER, J. CHRYSSOCHOOS, C. LARSEN, T. PEARSON, P. JENSEN, J. KAPP & P. LINSLEY. 1996. CTLA4-Ig prolongs survival of microencapsulated rabbit islet xenografts in spontaneously diabetic NOD mice. Transplant. Proc. 28: 821-823.
89. 89. WEBER, C., M. HAGLER, J. CHRYSSOCHOOS, G. KORBUTT, R. RAJOTTE, P. LINSLEY & J. KAPP. 1997. CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts diabetic NOD mice. Cell Transplant. 6: 505-508.